Advertisement
News
Subscribe to MDT Magazine News

Due to Rising Costs of Asthma and Chronic Obstructive Pulmonary Disease Drugs, Managed Care Organization Pharmacy Directors Will be Forced to Tighten Their Formularies

October 6, 2010 9:32 am | by Bio-Medicine.Org | Comments

NASHVILLE, Tenn. and GLEN ROCK, N.J., Oct. 6 /- HealthLeaders-InterStudy and Fingertip Formulary find that due to the rising costs of asthma and chronic obstructive pulmonary disease (COPD) drugs, managed care organization pharmacy directors will tighten their formularies. According to...

TOPICS:

New Technique Identifies Best Enzymes for Attacking Superbugs

October 6, 2010 8:34 am | by Georgia Tech Institute of Technology | Comments

New research published Oct. 4 in IOP Publishing's Physical Biology by scientists from Georgia Tech and the University of Maryland describes a pioneering method that can identify lytic enzymes for optimum bacteria-killing characteristics.

Baxano, Inc. Awarded Prestigious 2010 Spine Technology Awards

October 6, 2010 8:34 am | by Bio-Medicine.Org | Comments

SAN JOSE, Calif., Oct. 6 /- Baxano, Inc. ( www.baxano.com ) today announced that two of the company's products have been selected Best New Technology for Spine Care at the 2010 Spine Technology Awards. The iO-Flex™ System and the MicroBlade Shaver™ Device both received first...

TOPICS:
Advertisement

Orthopedics This Week Announces 2010 Best Spine Technology Award Winners

October 6, 2010 8:33 am | by Bio-Medicine.Org | Comments

WAYNE, Pa., Oct. 6 /- Orthopedics This Week, the most widely read publication in the orthopedics medical and business community today announced the winners of its 2010 Best Spine Technologies of the Year Award.  The annual awards honor the inventors and engineers for extraordinary...

TOPICS:

Obstetrics and Gynecology Publishes Data From Pivotal Phase 3 LYSTEDA Study

October 6, 2010 8:33 am | by Bio-Medicine.Org | Comments

PARSIPPANY, N.J., Oct. 6 /- Ferring Pharmaceuticals Inc. today announced publication of one of its pivotal Phase 3 trials of LYSTEDA™ (tranexamic acid) tablets for cyclic heavy menstrual bleeding (HMB) in the October issue of the peer-reviewed journal, Obstetrics & Gynecology ....

TOPICS:

Minnow Medical Bolsters Management Team

October 6, 2010 8:32 am | by Bio-Medicine.Org | Comments

LAGUNA HILLS, Calif., Oct. 6 /- Minnow Medical, Inc., a developer of a novel platform technology employing radiofrequency thermoplasty for the treatment of in-stent restenosis and other peripheral vascular conditions, announced today the appointment of two veteran medical device...

TOPICS:

AACR Hosts Cancer Prevention Meeting in Philadelphia

October 6, 2010 7:31 am | by AACR | Comments

This November, the American Association for Cancer Research will host its Ninth Annual International Conference on Frontiers in Cancer Prevention Research at the Pennsylvania Convention Center, located in Philadelphia. Thousands of scientists will gather to discuss new data on lifestyle...

TOPICS:

IPC to buy Premier for an undisclosed amount

October 6, 2010 6:45 am | by The Associated Press | Comments

Physician group practice company IPC The Hospitalist Company Inc. said Wednesday it bought Premier Hospitalists for an undisclosed amount.Premier is based in St. Louis and has an annual volume of about 20,000 patient encounters."We are pleased that this well-established practice has chosen to...

Advertisement

Positive Results From the MADIT-CRT Trial Support the Expanding Approval of Cardiac Resynchronization Therapy Defibrillators

October 6, 2010 6:31 am | by Bio-medicine.org | Comments

TORONTO, Oct. 6 /- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, growth in the $2 billion US cardiac resynchronization therapy defibrillator market will be supported by the expanded approval of Boston Scientific's chronic...

TOPICS:

Integra gets FDA clearance for back pain device

October 6, 2010 5:45 am | by The Associated Press | Comments

Integra LifeSciences Holdings Corp. said Wednesday it received Food and Drug Administration clearance to sell its Vu aPOD Prime anterior lumbar interbody fusion device.The device is used for a procedure to treat back pain by fusing vertebrae.Integra said the market for such procedures is...

Realizing Healthcare Savings Using Real-Time Technology

October 6, 2010 5:36 am | by Bio-Medicine.Org | Comments

CHICAGO, Oct. 6 /- Experiencing speed and efficiency in the healthcare process remains a rarity. Now two companies are adding those essential variables to ensure healthy, accurate outcomes. Rising Medical Solutions, a medical cost containment company, and Align Networks, a physical...

TOPICS:

100,000th Patient Treated With Accuray's CyberKnife® Robotic Radiosurgery System

October 6, 2010 5:34 am | by Bio-Medicine.Org | Comments

SUNNYVALE, Calif., Oct. 6 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that the 100,000th patient has been treated with the CyberKnife ® Robotic Radiosurgery System, a non-invasive alternative to surgery for the treatment of...

TOPICS:

MRI safety: Patients with insulin pumps require special cautions

October 6, 2010 5:34 am | by Diagnostic Imaging | Comments

An insulin pump allows the replacement of slow-acting insulin for basal needs with a continuous infusion of rapid-acting insulin. By using an insulin pump, a patient can typically match the dosage of insulin to lifestyle and activities, rather than adjusting those to the body’s response...

TOPICS:

Reproductive health: Checkerboard of infertility treatment in Europe

October 6, 2010 5:34 am | by EurekAlert | Comments

(European Society of Human Reproduction and Embryology) During the European Health Forum Gastein, the most important conference on health care policy in the EU, ESHRE highlighted the problems in medically assisted reproduction (MAR) regulation in Europe. The regulatory diversity in MAR is...

TOPICS:

CardioGenics Featured on Cover of Medical Device & Diagnostic Industry Magazine

October 6, 2010 5:33 am | by Bio-Medicine.Org | Comments

MISSISSAUGA, Ontario, Oct. 6 /- Dr. Yahia Gawad, CEO of CardioGenics Inc. (OTC Bulletin Board: CGNH ), has authored a cover story for this month's Medical Device & Diagnostic Industry Magazine (MD+DI) which addresses improvements in diagnostic times using point-of-care technology. In...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading